1Monteiro, R & Azevedo, I (2010) Chronic inflammation in obesity and the metabolic syndrome. Mediators Inflamm 2010, 1–10.
2Astrup, A, Buemann, B, Western, P, et al. (1994) Obesity as an adaptation to a high-fat diet: evidence from a cross-sectional study. Am J Clin Nutr 59, 350–355.
3World Health Organization (2011) Obesity and Overweight. Geneva: WHO.
4Henry, SL, Bensley, JG, Wood-Bradley, RJ, et al. (2012) White adipocytes: more than just fat depots. Int J Biochem Cell Biol 44, 435–440.
5Zhang, H & Zhang, C (2010) Adipose “talks” to distant organs to regulate insulin sensitivity and vascular function. Obesity (Silver Spring) 18, 2071–2076.
6Tilg, H, Trehu, E, Atkins, MB, et al. (1994) Interleukin 6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 83, 113–118.
7Eklund, CM (2009) Proinflammatory cytokines in CRP baseline regulation. Adv Clin Chem 48, 111–136.
8Arner, P (2003) The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones. Trends Endocrinol Metab 14, 137–145.
9Khera, TK, Dick, AD & Nicholson, LB (2010) Mechanisms of TNFα regulation in uveitis: focus on RNA-binding proteins. Prog Retin Eye Res 29, 610–621.
10Illán-Gómez, F, González-Ortega, M, Orea-Soler, I, et al. (2012) Obesity and inflammation: change in adiponectin, C reactive protein, tumor necrosis factor-alpha and interleukin-6 after bariatric surgery. Obes Surg 22, 950–955.
11Fantuzzi, G (2005) Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115, 911–919.
12Rasouli, N & Kern, PA (2008) Adipocytokines and the metabolic complications of obesity. J Clin Endocrinol Metab 93, S64–S73.
13Tarkowski, A, Bjersing, J, Shestakov, A, et al. (2010) Resistin competes with lipopolysaccharide for binding to Toll-like receptor 4. J Cell Mol Med 14, 1419–1431.
14Bokarewa, M, Nagaev, I, Dahlberg, L, et al. (2005) Resistin, an adipokine with potent proinflammatory properties. J Immunol 174, 5789–5795.
15Pagano, C, Soardo, G, Pilon, C, et al. (2006) Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance. J Clin Endocrinol Metab 91, 1081–1086.
16Singhal, NS, Patel, RT, Qi, Y, et al. (2008) Loss of resistin ameliorates hyperlipidemia and hepatic steatosis in leptin-deficient mice. Am J Physiol Endocrinol Metab 295, E331–E338.
17Indulekha, K, Anjana, RM, Surendar, J, et al. (2011) Association of visceral and subcutaneous fat with glucose intolerance, insulin resistance, adipocytokines and inflammatory markers in Asian Indians (CURES-113). Clin Biochem 44, 281–287.
18Stirnadel, H, Lin, X, Ling, H, et al. (2008) Genetic and phenotypic architecture of metabolic syndrome-associated components in dyslipidemic and normolipidemic subjects: the GEMS Study. Atherosclerosis 197, 868–876.
19Hauner, H (2005) Secretory factors from human adipose tissue and their functional role. Proc Nutr Soc 64, 163–169.
20Khachik, F, Carvalho, L, Bernstein, PS, et al. (2002) Chemistry, distribution, and metabolism of tomato carotenoids and their impact on human health. Exp Biol Med (Maywood) 227, 845–851.
21Mangels, AR, Holden, JM, Beecher, GR, et al. (1993) Carotenoid content of fruits and vegetables: an evaluation of analytic data. J Am Diet Assoc 93, 284–296.
22Di Mascio, P, Kaiser, S & Sies, H (1989) Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Biophys 274, 532–538.
23Wang, S, Konorev, EA, Kotamraju, S, et al. (2004) Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms. Intermediacy of H2O2- and p53-dependent pathways. J Biol Chem 279, 25535–25543.
24Ferreira, ALA, Russell, RM, Rocha, NS, et al. (2007) Effect of lycopene on doxorubicin-induced cardiotoxicity: an echocardiographic, histological, and morphometrical assessment. Basic Clin Pharmacol Toxicol 101, 16–24.
25Marcotorchino, J, Romier, B, Gouranton, E, et al. (2012) Lycopene attenuates LPS-induced TNF-α secretion in macrophages and inflammatory markers in adipocytes exposed to macrophage-conditioned media. Mol Nutr Food Res 56, 725–732.
26Bignotto, L, Rocha, J, Sepodes, B, et al. (2009) Anti-inflammatory effect of lycopene on carrageenan-induced paw oedema and hepatic ischaemia–reperfusion in the rat. Br J Nutr 102, 126–133.
27Hung, CF, Huang, TF, Chen, BH, et al. (2008) Lycopene inhibits TNF-alpha-induced endothelial ICAM-1 expression and monocyte endothelial adhesion. Eur J Pharmacol 586, 275–282.
28Gouranton, E, Thabuis, C, Riollet, C, et al. (2011) Lycopene inhibits proinflammatory cytokine and chemokine expression in adipose tissue. J Nutr Biochem 22, 642–648.
29Ghavipour, M, Saedisomeolia, A, Djalali, M, et al. (2013) Tomato juice consumption reduces systemic inflammation in overweight and obese females. Br J Nutr 109, 2031–2035.
30Nascimento, AF, Sugizaki, MM, Leopoldo, AS, et al. (2008) A hypercaloric pellet-diet cycle induces obesity and co-morbidities in Wistar rats. Arq Bras Endocrinol Metab 52, 968–974.
31Ibrahim, HS, Ahmed, LA & El-din, MME (2008) The functional role of some tomato products on lipid profile and liver function in adult rats. J Med Food 11, 551–559.
32Ali, MM & Agha, FG (2009) Amelioration of spreptozotocin induced diabetes mellitus oxidative stress and dyslipidemia in rats by tomato extract lycopene. Scand J Clin Lab Invest 69, 371–379.
33Bahcecioglu, IH, Kuzu, N, Metin, K, et al. (2010) Lycopene prevents development of steatohepatitis in experimental nonalcoholic steatohepatitis model induced by high-fat diet. Vet Med Int 2010, 1–8.
34Wang, Y, Ausman, LM, Greenberg, AS, et al. (2010) Dietary lycopene and tomato extract supplementations inhibit nonalcoholic steatohepatitis-promoted hepatocarcinogenesis in rats. Int J Cancer 126, 1788–1796.
35Gea-Sorlí, S, Bonjoch, L & Closa, D (2012) Differences in the inflammatory response induced by acute pancreatitis in different white adipose tissue sites in the rat. PLOS ONE 7, e41933.
36Yeum, KJ, Booth, SL, Sadowski, JA, et al. (1996) Human plasma carotenoid response to the ingestion of controlled diets high in fruits and vegetables. Am J Clin Nutr 64, 594–602.
37Nascimento, AF, Luvizotto, RA, Leopoldo, AS, et al. (2011) Long-term high-fat diet-induced obesity decreases the cardiac leptin receptor without apparent lipotoxicity. Life Sci 88, 1031–1038.
38Coatmellec-Taglioni, G, Dausse, JP, Ribière, C, et al. (2000) Hypertension in cafeteria-fed rats: alterations in renal alpha2-adrenoceptor subtypes. Am J Hypertens 13, 529–534.
39Livak, KJ & Schmittgen, TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25, 402–408.
40Jang, AS, Kim, TH, Park, JS, et al. (2009) Association of serum leptin and adiponectin with obesity in asthmatics. J Asthma 46, 59–63.
41van Dijk, SJ, Feskens, EJ, Bos, MB, et al. (2009) A saturated fatty acid-rich diet induces an obesity-linked proinflammatory gene expression profile in adipose tissue of subjects at risk of metabolic syndrome. Am J Clin Nutr 90, 1656–1664.
42Boileau, TW, Boileau, AC & Erdman, JW (2002) Bioavailability of all-trans and cis-isomers of lycopene. Exp Biol Med (Maywood) 227, 914–919.
43Mathews-Roth, MM, Welankiwar, S, Sehgal, PK, et al. (1990) Distribution of [14C] canthaxanthin and [14C] lycopene in rats and monkeys. J Nutr 120, 1205–1213.
44Hariri, N & Thibault, L (2010) High-fat diet-induced obesity in animal models. Nutr Res Rev 23, 270–299.
45Ainslie, DA, Proietto, J, Fam, BC, et al. (2000) Short-term, high-fat diets lower circulating leptin concentrations in rats. Am J Clin Nutr 71, 438–442.
46Roberts, CK, Barnard, RJ, Liang, KH, et al. (2002) Effect of diet on adipose tissue and skeletal muscle VLDL receptor and LPL: implications for obesity and hyperlipidemia. Atherosclerosis 161, 133–141.
47Nascimento, AF, Sugizaki, MM, Leopoldo, AS, et al. (2008) Misclassification probability as obese or lean in hypercaloric and normocaloric diet. Biol Res 41, 253–259.
48Tentolouris, N, Pavlatos, S, Kokkinos, A, et al. (2008) Diet-induced thermogenesis and substrate oxidation are not different between lean and obese women after two different isocaloric meals, one rich in protein and one rich in fat. Metabolism 57, 313–320.
49Schrauwen, P & Westerterp, KR (2000) The role of high-fat diets and physical activity in the regulation of body weight. Br J Nutr 84, 417–427.
50Hotamisligil, GS (2003) Inflammatory pathways and insulin action. Int J Obes Relat Metab Disord 27, Suppl. 3, S53–S55.
51White, MF (2003) Insulin signalling in health and disease. Science 302, 1710–1711.
52Pirola, L, Johnston, AM & Van Obberghen, E (2004) Modulation of insulin action. Diabetologia 47, 170–184.
53Bennet, PA, Lindell, K, Karlsson, C, et al. (1998) Differential expression and regulation of leptin receptor isoforms in the rat brain: effects of fasting and oestrogen. Neuroendocrinology 67, 29–36.
54López, IP, Marti, A, Milagro, FI, et al. (2003) DNA microarray analysis of genes differentially expressed in diet-induced (cafeteria) obese rats. Obes Res 11, 188–194.
55Wang, M, Orci, L, Ravazzola, M, et al. (2005) Fat storage in adipocytes requires inactivation of leptin's paracrine activity: implications for treatment of human obesity. PNAS 102, 18011–18016.
56Frederich, RC, Löllmann, B, Hamann, A, et al. (1995) Expression of ob mRNA and its encoded protein in rodents. Impact of nutrition and obesity. J Clin Invest 96, 1658–1663.
57Luvizotto, RA, Nascimento, AF, Síbio, MT, et al. (2012) Experimental hyperthyroidism decreases gene expression and serum levels of adipokines in obesity. ScientificWorldJournal 2012, 780890.
58Sierra-Honigmann, MR, Nath, AK, Murakami, C, et al. (1998) Biological action of leptin as an angiogenic factor. Science 281, 1683–1686.
59Lee, SW, Park, MC, Park, YB, et al. (2007) Measurement of the serum leptin level could assist disease activity monitoring in rheumatoid arthritis. Rheumatol Int 27, 537–540.
60Targonska-Stepniak, B, Majdan, M & Dryglewska, M (2008) Leptin serum levels in rheumatoid arthritis patients: relation to disease duration and activity. Rheumatol Int 28, 585–591.
61Gregor, MF & Hotamisligil, GS (2011) Inflammatory mechanisms in obesity. Annu Rev Immunol 29, 415–445.
62Satapathy, SK, Ochani, M, Dancho, M, et al. (2011) Galantamine alleviates inflammation and other obesity-associated complications in high-fat diet-fed mice. Mol Med 17, 599–606.
63Steppan, CM, Bailey, ST, Bhat, S, et al. (2001) The hormone resistin links obesity to diabetes. Nature 409, 307–312.
64Ohmori, R, Momiyama, Y, Kato, R, et al. (2005) Associations between serum resistin levels and insulin resistance, inflammation, and coronary artery disease. J Am Coll Cardiol 46, 379–380.
65Reilly, MP, Lehrke, M, Wolfe, ML, et al. (2005) Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 111, 932–939.
66Zhang, Z, Xing, X, Hensley, G, et al. (2010) Resistin induces expression of proinflammatory cytokines and chemokines in human articular chondrocytes via transcription and messenger RNA stabilization. Arthritis Rheum 62, 1993–2003.
67Kuzmicki, M, Telejko, B, Szamatowicz, J, et al. (2009) High resistin and interleukin-6 levels are associated with gestational diabetes mellitus. Gynecol Endocrinol 25, 258–263.